共 50 条
- [3] Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (04):
- [6] Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):
- [10] Risk factors for stroke in Chinese with atrial fibrillation: Case-control study CLINICAL CARDIAC PACING AND ELECTROPHYSIOLOGY, 2003, : 569 - 573